Elutia Inc. SEC filings ELUT
Elutia Inc. has 369 filings in SEC EDGAR's recent list, going back to Jun 9, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 21, 2026 (acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Aug 21, 2026 | Aug 17, 2026 |
| S-8 | Employee stock plan registration | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 11, 2026 | — |
| 8-K |
Current report
Listing notice
|
Aug 7, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 20, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 21, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Apr 14, 2026 | Dec 10, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 28, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 2, 2026 | Dec 23, 2025 |
| 144 | Notice of proposed sale | Dec 23, 2025 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 4/A | Ownership document | Dec 19, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 17, 2025 |
| 4/A | Ownership document | Dec 17, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Dec 2, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 12, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 14, 2025 | Oct 7, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 9, 2025 |
| 3 | Initial insider ownership | Oct 14, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Oct 7, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 9, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 20, 2025 | Aug 15, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 424B5 | Prospectus supplement | May 8, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
May 6, 2025 | Apr 30, 2025 |
| 424B5 | Prospectus supplement | Apr 11, 2025 | — |
| EFFECT | Filing | Apr 7, 2025 | — |
| CORRESP | Letter to the SEC | Apr 7, 2025 | — |
| ARS | Annual report to shareholders | Apr 4, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 4, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | May 29, 2025 |
| UPLOAD | Letter from the SEC | Mar 25, 2025 | — |
| S-3 | Shelf registration | Mar 18, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 13, 2025 | — |
| 4 | Insider transaction | Mar 13, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 8, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 4, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2025 | — |
| 4 | Insider transaction | Dec 11, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 10, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 15, 2024 | — |
| 8-K |
Current report
Material agreement, New debt
|
Oct 3, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2024 | Jun 16, 2024 |
| 424B5 | Prospectus supplement | Jun 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 1, 2024 | Mar 27, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 8, 2024 |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 4/A | Ownership document | Feb 20, 2024 | Mar 23, 2023 |
| 3/A | Ownership document | Feb 20, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 424B3 | Prospectus | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 2, 2024 | Jan 31, 2024 |
| S-8 | Employee stock plan registration | Jan 25, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 12, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Other events
|
Jan 10, 2024 | Jan 10, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 9, 2024 | — |
| 4 | Insider transaction | Jan 8, 2024 | Dec 28, 2023 |
| 4 | Insider transaction | Jan 8, 2024 | Dec 28, 2023 |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 27, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 8, 2023 | Dec 8, 2023 |
| 424B3 | Prospectus | Dec 5, 2023 | — |
| EFFECT | Filing | Dec 4, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Dec 4, 2023 | — |
| CORRESP | Letter to the SEC | Nov 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| S-3 | Shelf registration | Nov 20, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Nov 15, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 7, 2023 | Nov 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 6, 2023 | — |
| 4 | Insider transaction | Oct 5, 2023 | Sep 21, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Sep 21, 2023 |
| 3 | Initial insider ownership | Oct 5, 2023 | Sep 21, 2023 |
| D | Filing | Oct 3, 2023 | — |
| 4 | Insider transaction | Sep 21, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 19, 2023 | Sep 17, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 7, 2023 | Sep 6, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 13, 2023 | Jul 13, 2023 |
| 4 | Insider transaction | Jun 23, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ELUT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Silver Spring, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1708527
- Former names
- AZIYO BIOLOGICS, INC. (until Aug 14, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.